This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
legalizes marijuana. Here are three reasons marijuana legalization in the U.S. If a company is using up a lot of cash over the course of its operations, then there's a risk that it will need to issue shares, and thus dilute its existing shareholders and put downward pressure on the stock price. won't solve Tilray's problems.
Sirius XM is a legal monopoly that generates more than three-quarters of its net sales from subscriptions. Similar to Sirius XM, VeriSign is a legal monopoly, and it possesses impressive pricing power. Steadily reducing the company's share count helps to gradually increase the ownership stakes of existing shareholders.
In the quarter, we continue to execute against our strategy that is driving long-term growth and shareholder value. We're very pleased with Enact's operational strength's capital levels and consistent shareholder distributions. Our first priority is to create shareholder value through Enact's growing market value and returns.
The global cannabis market is poised for explosive growth between 2024 and 2030, as more countries legalize marijuana for medical and recreational use. According to a report by Grand View Research, the global legal marijuana market is expected to reach $102.2 billion by 2030, representing a compound annual growth rate (CAGR) of 25.7%
Under the terms of the merger, shareholders of NeueHealth common stock (excluding certain shares and those that will be rolled over) will receive $7.33 These shareholders will exchange their common and/or preferred stock for newly issued equity in the privately held company.
The New York-based private equity firm, which focuses on middle-market buyouts and growth investments, first backed Simple Mills in October 2019, becoming its largest shareholder. Piper Sandler and Centerview Partners acted as financial advisors, while Kirkland & Ellis served as legal counsel to Vestar on the transaction.
Latham & Watkins served as legal counsel to Carlyle. Zulli, Tabanelli, e Associati and Perris e Associati served as financial advisors to Spezzapria family minority shareholders.
In addition, just this past week, the German Federal Ministry and Minister of Food and Agriculture approved the plan to allow research-focused commercial cannabis pilot programs to test legal and regulated access to cannabis for consumers. And we are working to reach out to understand their position on cannabis.
marijuana market in the event that there is federal cannabis legalization is looking quite rickety. If legalization happens, Tilray has the right to convert the notes into a minority stake in MedMen, so it would in theory have access to the U.S. In other words, marijuana legalization in the U.S. In August 2021 it purchased $165.8
Another key element of the bear thesis is that big catalysts, like cannabis legalization in the U.S. Per management and the bulls, such legal breakthroughs are perpetually six months away. such that it can realize global economies of scale in production once cannabis is fully legalized in those regions. and the E.U.,
This achievement is particularly noteworthy given the company's history of cash burn and shareholder dilution. country to legalize cannabis for recreational use. The company operates in a highly regulated industry with ongoing legal uncertainties in multiple key geographies. The company achieved positive free cash flow of CA$6.5
Let's discuss what would make it into a home run for shareholders so that you'll be equipped to determine if the tide is turning in its favor in the near future. countries, and it also aspires to sell recreational cannabis where and when it is legal to do so. For instance, if there is cannabis legalization in the U.S.,
Citizens served as financial advisor and Locke Lord served as legal advisor to Pearl Meyer and its shareholders. Ropes & Gray served as legal advisor to Coalesce Capital. Financial terms of the transaction have not been disclosed.
25, today's announcement about the capital restructuring move comes with an important detail that shareholders are likely unhappy about. This means that if a shareholder owns 109 shares of Canopy stock, they will receive only 10 shares of stock on a reverse-split-adjusted basis. What comes next for Canopy Growth stock?
I am incredibly excited about this acquisition, which enhances our footprint in some of the most bet-upon sports, including tennis, soccer, and basketball, and will deliver significant value to our clients, partners, and shareholders. Now that that is behind us, once the window opens up again, we will look to return capital to shareholders.
in advance of federal-level marijuana legalization. To accomplish that, on April 15 shareholders voted in favor of creating a new class of exchangeable shares. penetrates state-level markets, its value could grow, and full legalization would send that into overdrive. In short, it created a parallel business, Canopy U.S.A.,
The results are a breath of fresh air for shareholders, who've seen the stock decline by 70% in the past three years. And major potential catalysts like cannabis legalization in the U.S. There's little indication that legalization in any of its target markets is happening soon. It's still deeply unprofitable.
Growth stocks can generate sizable gains for their shareholders. Sports betting is one such industry -- and DraftKings (NASDAQ: DKNG) is the best wager to make on the legalization megatrend. Widening budget needs are driving more governments to boost their tax revenue by legalizing sports gambling. Growth stock to buy No.
Political and legal pressure mounts Supermicro's management blames the margin erosion on competition and a tight inventory of key components. It also won't address the growing legal uncertainty surrounding the company. It shares this business model with rivals like Dell and Hewlett Packard Enterprise.
That happened on Thursday with top Canadian cannabis company Tilray Brands (NASDAQ: TLRY) , following news of a development in the legal sphere. Finally, he accused Hexo of engineering a 2020 reverse stock split in order to essentially harm shareholders. Tilray's shares enjoyed a 9% pop on this news, comparing most favorably to the 0.3%
Since the release of the Surgeon General's report on smoking 60 years ago, usage has declined and tobacco companies like Altria had to pay out hundreds of billions of dollars in legal settlements. That situation should put shareholders on notice, forcing them to consider whether they should stay in Altria stock amid this uncertainty.
Abbott is a longtime leader in the healthcare sector, and has generally delivered excellent returns to long-term shareholders. And detractors will point out that Abbott has encountered some headwinds lately, especially on the legal and regulatory fronts. First, as mentioned earlier, it's faced legal and regulatory issues.
This included a $355 million benefit from legal settlements, which are now materially complete. Our first priority is to create shareholder value through our approximately 81% ownership stake in Enact. As indicated on its earnings call, Enact expects to return similar levels of capital to its shareholders in 2025 as it did in 2024.
The rescheduling of cannabis from a Schedule I substance down to Schedule III, assuming it ends up happening, could help lower the tax bill for pot producers and make it easier to research cannabis, but it falls short of legalization and may not lead to cannabis companies being able to trade on a top U.S. But for U.S.-based
You are not required to hire a lawyer There is no requirement that you hire legal help to assist you with the incorporation process. Getting legal advice on these issues can help ensure you don't make a costly mistake that could come back to haunt you. Here's what you need to know. In fact, I incorporated my business on my own.
The utilities sector has historically underperformed the S&P 500 Utilities companies are often legal monopolies that generate consistent but slow-growing earnings. Vistra is largest competitive power generator in the U.S., Image source: Getty Images. The Vanguard Utilities ETF is a cheap and easy way to capitalize on that possibility.
While prime editing is an intriguing concept, this technology is still in its infancy, which poses a bevy of unique risks for early shareholders. Boasting a well-established distribution network throughout Germany and an EU-GMP certified facility in Portugal, Tilray is primed to amplify its operations as soon as legal conditions permit.
More than a few are seeing their stocks approach one-year highs, thanks to optimism about impending legalization and improving fundamentals. Quick and opportunistic, Green Thumb was fast to establish networks of its Rise dispensaries in Minnesota and Ohio, two of the three states that legalized recreational pot in 2023.
Will the returns during its next half-decade make the ongoing struggles worth it for shareholders? The idea is that if those markets legalize marijuana for adult use, the company already has some infrastructure in place to serve the anticipated rise in demand. It's possible. Here's why. Can it make more money than it spends?
Competing in alcohol is a net benefit for shareholders because it reduces the effect of detrimental legislation or market factors affecting the cannabis market. if cannabis legalization occurs, it'll be well-positioned to distribute its marijuana products everywhere, which could be a major boon. And make no mistake – it is coming.
Teaming up with Constellation Brands would give Canopy Growth access to significant funds to expand its operations without diluting shareholders, or so the argument went. That's to say nothing of the competing illegal market, the legal problems in the U.S., market once the country legalizes pot at the federal level.
Johnson & Johnson: $163 per share Johnson & Johnson's legal and regulatory problems have somewhat overshadowed its business results during the past few years. On the legal front, it is still dealing with thousands of lawsuits from people who allege that its talc-based products caused their cancers.
Under Linton, Canopy was a leading, growth-focused cannabis company Linton was long seen as Canopy's visionary, and he helped set up its conditional agreement to acquire multi-state operator Acreage Holdings , planning to move forward with a merger once marijuana became legal throughout the U.S. Today, it's still in much the same situation.
Aurora Cannabis (NASDAQ: ACB) has perhaps been the most disappointing pot stock since Canada legalized adult recreational uses of marijuana back in 2018 -- and that's saying something. Aurora Cannabis' revenue growth has been unimpressive in the past five years after initially soaring once pot became legal in Canada.
The cannabis industry continues to contend with mixed legislation and legalization at the state level while a total federal ban on marijuana remains in place. Innovative Industrial Properties looks well-positioned to continue its favorable growth trajectory, and long-term shareholders could be rewarded in kind as the decade proceeds.
See, not only have states only staggered into the legalization camp since 2018, but it also takes some time for the sports betting industry to fully mature in a particular market once DraftKings sets up shop. Starbucks shareholders are also excited to know Brian Niccol will be taking the helm as CEO next month.
These leaders in healthcare have been rewarding shareholders for decades and should continue to do so for a long time. Abbott should continue rewarding its shareholders with regular dividend hikes for a long time. Johnson & Johnson Johnson & Johnson also has its share of problems, especially on the legal front.
The industrial conglomerate has had to deal with a large number of legal issues recently, but reports suggested that 3M might be closer to putting another major problem behind it. It's never good news for companies to pay for doing harm, but most 3M shareholders had expected far worse. Several stock analysts believe that the $5.5
He legally isn't required to tell Wall Street or investors anything else about his company's BofA position until then. What we won't know is if Buffett undertakes any additional selling of Bank of America's stock from Oct. 11 through Dec. Berkshire Hathaway won't file the 13F detailing fourth-quarter trading activity until Feb.
You may even be a shareholder. In states where it's legal to do so, its app and website allow consumers to place various wagers on a wide range of sporting events. The legalization movement is gaining traction, though. As the adage goes, though, past performance is no guarantee of future results.
During Berkshire Hathaway's annual shareholder meeting in early May, he opined that the corporate tax rate would likely climb in the future. Perhaps Buffett's favorite trait about Sirius XM is that it's a legal monopoly. 1 position. This works out to almost a third of the company's outstanding shares.
What stalled the momentum this week was likely a lawsuit filed by shareholders of the company, alleging certain false and misleading statements and failure to disclose connections with the underwriter of the IPO, investment bank B. It has been on a tear this year, with its stock price up nearly 225%, trading at $6 per share.
This is despite the fact that marijuana has been legal to sell in Canopy's home country of Canada since 2018. And after today's sell-off, it means shareholders can anticipate Canopy having to sell as many as 32 million shares in order to raise the $250 million it needs. Why are investors upset with Canopy Growth?
For longtime shareholders of Sundial Growers, now known as SNDL , (NASDAQ: SNDL) the fun looks like it's finally starting. it has exposure to market growth if federal marijuana legalization ever passes. It's also the biggest private-sector retailer of liquor in the country. And via its cannabis investments in the U.S.,
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content